Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
July-2022 Volume 24 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2022 Volume 24 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis

  • Authors:
    • Ryuji Kojima
    • Esraa Hassan
    • Fumiko Ozawa
    • Chisato Yamada‑Namikawa
    • Shino Ogawa
    • Shoko Mase
    • Shinobu Goto
    • Ryutaro Nishikawa
    • Hiroshi Inagaki
    • Yoichi Kato
    • Mayumi Sugiura‑Ogasawara
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics and Gynecology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467‑8601, Japan, Department of Cell Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467‑8601, Japan, Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467‑8601, Japan
    Copyright: © Kojima et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 214
    |
    Published online on: May 17, 2022
       https://doi.org/10.3892/ol.2022.13334
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to examine primary cilia in endometrial tissue during the menstrual cycle and to clarify their morphological changes with different grades of endometrial cancer. Images of fluorescence immunostaining taken by confocal microscopy were used to count the number of primary cilia in normal endometrium and endometrioid carcinoma Grade 1 and Grade 3 specimens. To examine the association between autophagy and ciliogenesis in endometrioid carcinoma, the expression of p62/Sequestosome‑1, a selective substrate for autophagy, and oral‑facial‑digital syndrome 1 protein (OFD1), a protein associated with ciliogenesis, were examined using images of fluorescence immunostaining taken by confocal microscopy. The level of p62 expression was confirmed by western blotting. In proliferative and secretory endometrial stromal cells, the percentage of cells that were ciliated was 7.2 and 32.7% (95% confidence interval=21.61‑39.79; P<0.01), and the length of the primary cilia was 1.24 µm and 2.34 µm (0.92‑1.26; P<0.01), respectively. In stromal cells of endometrioid carcinoma Grade 1 and Grade 3, the percentage of ciliated cells was 13.5 and 2.9% (7.89‑15.05; P<0.001), and the length of the primary cilia was 2.02 and 1.14 µm (0.76‑0.99; P<0.001), respectively. In both normal menstrual cycle tissue and endometrial carcinomas, the percentage of primary cilia was lower and their length was shorter in tissues with higher proliferative potential. The expression of OFD1 was significantly higher in Grade 3 compared with Grade 1 as indicated by quantifying the intensity of the fluorescence images (133‑12248; P=0.046). To the best of our knowledge, this is the first study concerning the distribution of primary cilia in normal endometrium and endometrial cancer tissues. Overall, fewer ciliated cells in the highly malignant endometrial cancer tissues may be associated not only to the proliferation of cancer cells, but also to the excessive accumulation of OFD1 due to dysfunctional autophagy.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Breslow DK and Holland AJ: Mechanism and regulation of centriole and cilium biogenesis. Annu Rev Biochem. 88:691–724. 2019. View Article : Google Scholar : PubMed/NCBI

2 

Goto H, Inoko A and Inagaki M: Cell cycle progression by the repression of primary cilia formation in proliferating cells. Cell Mol Life Sci. 70:3893–3905. 2013. View Article : Google Scholar

3 

Goranova V and Chaldakov GN: Ciliated fibroblasts and smooth cells in the rat uterus. Experientia. 46:488–489. 1990. View Article : Google Scholar

4 

Sarkisian MR, Siebzehnrubl D, Hoang-Minh L, Deleyrolle L, Silver DJ, Siebzehnrubl FA, Guadiana SM, Srivinasan G, Semple-Rowland S, Harrison JK, et al: Detection of primary cilia in human glioblastoma. J Neurooncol. 117:15–24. 2014. View Article : Google Scholar

5 

Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK, Epstein EH Jr, Dlugosz AA and Reiter JF: Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med. 15:1055–1061. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Rocha C, Papon L, Cacheux W, Marques Sousa P, Lascano V, Tort O, Giordano T, Vacher S, Lemmers B, Mariani P, et al: Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon. EMBO J. 33:2247–2260. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Egeberg DL, Lethan M, Manguso R, Schneider L, Awan A, Jørgensen TS, Byskov AG, Pedersen LB and Christensen ST: Primary cilia and aberrant cell signaling in epithelial ovarian cancer. Cilia. 1:152012. View Article : Google Scholar

8 

Hassounah NB, Nunez M, Nunez M, Fordyce C, Roe D, Nagle R, Bunch T and McDermott KM: Inhibition of ciliogenesis promotes Hedgehog signaling, tumorigenesis, and metastasis in breast cancer. Mol Cancer Res. 15:1421–1430. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Hassounah NB, Nagle R, Saboda K, Roe DJ, Dalkin BL and McDermott KM: Primary cilia are lost in preinvasive and invasive prostate cancer. PLoS One. 8:e685212013. View Article : Google Scholar : PubMed/NCBI

10 

Lin CJ, Dang A, Hernandez E and Hsieh JT: DAB2IP modulates primary cilia formation associated with renal tumorigenesis. Neoplasia. 23:169–180. 2021. View Article : Google Scholar

11 

Kobayashi T, Nakazono K, Tokuda M, Mashima Y, Dynlacht BD and Itoh H: HDAC2 promotes loss of primary cilia in pancreatic ductal adenocarcinoma. EMBO Rep. 18:334–343. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Gradilone SA, Radtke BN, Bogert PS, Huang BQ, Gajdos GB and LaRusso NF: HDAC6 inhibition restores ciliary expression and decreases tumor growth. Cancer Res. 73:2259–2270. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Barakat MT, Humke EW and Scott MP: Kif3a is necessary for initiation and maintenance of medulloblastoma. Carcinogenesis. 34:1382–1392. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Concin N, Matias-Guiu X, Vergote I, Cibula D, Mizra MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, et al: ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 31:12–39. 2021. View Article : Google Scholar : PubMed/NCBI

15 

Yamagami W, Mikami M, Nagase S, Tabata T, Kobayashi Y, Kaneuchi M, Kobayashi H, Yamada H, Hasegawa K, Fujiwara H, Katabuchi H and Aoki D: Initial treatment for endometrial cancer. In: Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms. J Gynecol Oncol. 31:e182020. View Article : Google Scholar

16 

Nagase S, Ohta T, Takahashi F and Yaegashi N; Board Members of the 2020 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology, . Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2017 and Annual Treatment Report for 2012. J Obstet Gynaecol Res. 47:1631–1642. 2021. View Article : Google Scholar : PubMed/NCBI

17 

WHO Classification of Tumors Editorial Board, . WHO classification of tumours. 5th edition. Vol. 4. Female Genital Tumors. World Health Organization; 2020

18 

Gould PR, Li L, Henderson DW, Barter RA and Papadimitriou JM: Cilia and ciliogenesis in endometrial adenocarcinomas. An ultrastructural analysis. Ach Patho Lab Med. 110:326–330. 1986.

19 

Haibach H, Oxenhandler RW and Luger AM: Ciliated adenocarcinoma of the endometrium. Acta Obstet Gynecol Scand. 64:457–462. 1985. View Article : Google Scholar : PubMed/NCBI

20 

Tang Z, Lin MG, Stowe TR, Chen S, Zhu M, Stearns T, Franco B and Zhong Q: Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar satellites. Nature. 502:254–257. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Lee J, Yi S, Kang YE, Chang JY, Kim JT, Sul HJ, Kim JO, Kim JM, Kim J, Porcelli AM, et al: Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy. Oncotarget. 7:79117–79130. 2016. View Article : Google Scholar

22 

Inami Y, Waguri S, Sakamoto A, Kouno T, Nakada K, Hino O, Watanabe S, Ando J, Iwadate M, Yamamoto M, et al: Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol. 193:275–284. 2011. View Article : Google Scholar

23 

Ko JY, Lee EJ and Park JH: Interplay between primary cilia and autophagy and its controversial roles in cancer. Biomol Ther (Seoul). 27:337–341. 2019. View Article : Google Scholar : PubMed/NCBI

24 

Nucci MR: Gynecologic pathology. A volume in foundations in diagnostic pathology series. 2nd edition. Elsevier; 2019

25 

Meng HX, Yang XX, Liu RQ, Bao JJ, Hou YJ, Sun J, Miao SS and Qu GF: The Relationship between human papillomavirus, OFD1 and primary ciliogenesis in the progression of oropharyngeal cancer: A retrospective cohort study. Pharmgenomics Pers Med. 13:633–644. 2020.PubMed/NCBI

26 

Ford MJ, Yeyati PL, Mali GR, Keighren MA, Waddell SH, Mjoseng HK, Douglas AT, Hall EA, Sakaue-Sawano A, Miyawaki A, et al: A cell/cilia biosensor for single-cell kinetics reveals persistence of cilia after G1/S transition is a general property in cells and mice. Dev Cell. 47:509–523.e5. 2018. View Article : Google Scholar

27 

Gabriel E, Wason A, Ramani A, Gooi LM, Keller P, Pozniakovsky A, Poser I, Noack F, Telugu NS, Calegari F, et al: CPAP promotes timely cilium disassembly to maintain neural progenitor pool. EMBO J. 35:803–819. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Liu L, Sheng JQ, Wang MR, Gan Y, Wu XL, Liao JZ, Tian DA, He XX and Li PY: Primary cilia blockage promotes the malignant behaviors of hepatocellular carcinoma via induction of autophagy. Biomed Res Int. 2019:52027502019.

29 

Cai-McRae X and Karantza V: p62: A hub of multiple signaling pathways in HER2-induced mammary tumorigenesis. Mol Cell Oncol. 2:e9750352015. View Article : Google Scholar

30 

Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, et al: Autophagy suppresses tumorigenesis through elimination of p62. Cell. 137:1062–1075. 2009. View Article : Google Scholar

31 

Lei C, Zhao B, Liu L, Zeng X, Yu Z and Wang X: Expression and clinical significance of p62 protein in colon cancer. Medicine (Baltimore). 99:e187912020. View Article : Google Scholar : PubMed/NCBI

32 

Iwadate R, Inoue J, Tsuda H, Takano M, Furuya K, Hirasawa A, Aoki D and Inazawa J: High expression of SQSTM1/p62 protein is associated with poor prognosis in epithelial ovarian cancer. Acta Histochem Cytochem. 47:295–301. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Iwadate R, Inoue J, Tsuda H, Takano M, Furuya K, Hirasawa A, Aoki D and Inazawa J: High expression of p62 protein is associated with poor prognosis and aggressive phenotypes in endometrial cancer. Am J Pathol. 185:2523–2533. 2015. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kojima R, Hassan E, Ozawa F, Yamada‑Namikawa C, Ogawa S, Mase S, Goto S, Nishikawa R, Inagaki H, Kato Y, Kato Y, et al: Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis. Oncol Lett 24: 214, 2022.
APA
Kojima, R., Hassan, E., Ozawa, F., Yamada‑Namikawa, C., Ogawa, S., Mase, S. ... Sugiura‑Ogasawara, M. (2022). Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis. Oncology Letters, 24, 214. https://doi.org/10.3892/ol.2022.13334
MLA
Kojima, R., Hassan, E., Ozawa, F., Yamada‑Namikawa, C., Ogawa, S., Mase, S., Goto, S., Nishikawa, R., Inagaki, H., Kato, Y., Sugiura‑Ogasawara, M."Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis". Oncology Letters 24.1 (2022): 214.
Chicago
Kojima, R., Hassan, E., Ozawa, F., Yamada‑Namikawa, C., Ogawa, S., Mase, S., Goto, S., Nishikawa, R., Inagaki, H., Kato, Y., Sugiura‑Ogasawara, M."Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis". Oncology Letters 24, no. 1 (2022): 214. https://doi.org/10.3892/ol.2022.13334
Copy and paste a formatted citation
x
Spandidos Publications style
Kojima R, Hassan E, Ozawa F, Yamada‑Namikawa C, Ogawa S, Mase S, Goto S, Nishikawa R, Inagaki H, Kato Y, Kato Y, et al: Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis. Oncol Lett 24: 214, 2022.
APA
Kojima, R., Hassan, E., Ozawa, F., Yamada‑Namikawa, C., Ogawa, S., Mase, S. ... Sugiura‑Ogasawara, M. (2022). Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis. Oncology Letters, 24, 214. https://doi.org/10.3892/ol.2022.13334
MLA
Kojima, R., Hassan, E., Ozawa, F., Yamada‑Namikawa, C., Ogawa, S., Mase, S., Goto, S., Nishikawa, R., Inagaki, H., Kato, Y., Sugiura‑Ogasawara, M."Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis". Oncology Letters 24.1 (2022): 214.
Chicago
Kojima, R., Hassan, E., Ozawa, F., Yamada‑Namikawa, C., Ogawa, S., Mase, S., Goto, S., Nishikawa, R., Inagaki, H., Kato, Y., Sugiura‑Ogasawara, M."Abnormal accumulation of OFD1 in endometrial cancer with poor prognosis inhibits ciliogenesis". Oncology Letters 24, no. 1 (2022): 214. https://doi.org/10.3892/ol.2022.13334
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team